198 related articles for article (PubMed ID: 1813780)
1. A hemA mutation renders Salmonella typhimurium avirulent in mice, yet capable of eliciting protection against intravenous infection with S. typhimurium.
Benjamin WH; Hall P; Briles DE
Microb Pathog; 1991 Oct; 11(4):289-95. PubMed ID: 1813780
[TBL] [Abstract][Full Text] [Related]
2. Immunity conferred by Aro- Salmonella live vaccines.
Hormaeche CE; Joysey HS; Desilva L; Izhar M; Stocker BA
Microb Pathog; 1991 Feb; 10(2):149-58. PubMed ID: 1890952
[TBL] [Abstract][Full Text] [Related]
3. Virulence and vaccine potential of Salmonella typhimurium mutants deficient in the expression of the RpoS (sigma S) regulon.
Coynault C; Robbe-Saule V; Norel F
Mol Microbiol; 1996 Oct; 22(1):149-60. PubMed ID: 8899717
[TBL] [Abstract][Full Text] [Related]
4. A Salmonella typhimurium mutant unable to utilize fatty acids and citrate is avirulent and immunogenic in mice.
Utley M; Franklin DP; Krogfelt KA; Laux DC; Cohen PS
FEMS Microbiol Lett; 1998 Jun; 163(2):129-34. PubMed ID: 9673014
[TBL] [Abstract][Full Text] [Related]
5. Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium.
Rondini S; Micoli F; Lanzilao L; Gavini M; Alfini R; Brandt C; Clare S; Mastroeni P; Saul A; MacLennan CA
Infect Immun; 2015 Mar; 83(3):996-1007. PubMed ID: 25547792
[TBL] [Abstract][Full Text] [Related]
6. Aromatic-dependent "Salmonella sp." as live vaccine in mice and calves.
Stocker BA; Hoiseth SK; Smith BP
Dev Biol Stand; 1983; 53():47-54. PubMed ID: 6307785
[TBL] [Abstract][Full Text] [Related]
7. Influence of the Salmonella typhimurium pathogenicity island 2 type III secretion system on bacterial growth in the mouse.
Shea JE; Beuzon CR; Gleeson C; Mundy R; Holden DW
Infect Immun; 1999 Jan; 67(1):213-9. PubMed ID: 9864218
[TBL] [Abstract][Full Text] [Related]
8. Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.
Tennant SM; Schmidlein P; Simon R; Pasetti MF; Galen JE; Levine MM
Infect Immun; 2015 Dec; 83(12):4504-12. PubMed ID: 26351285
[TBL] [Abstract][Full Text] [Related]
9. Immunity induced by live attenuated Salmonella vaccines.
Hormaeche CE; Joysey HS; Desilva L; Izhar M; Stocker BA
Res Microbiol; 1990; 141(7-8):757-64. PubMed ID: 2101466
[TBL] [Abstract][Full Text] [Related]
10. A Salmonella enterica serovar typhimurium succinate dehydrogenase/fumarate reductase double mutant is avirulent and immunogenic in BALB/c mice.
Mercado-Lubo R; Gauger EJ; Leatham MP; Conway T; Cohen PS
Infect Immun; 2008 Mar; 76(3):1128-34. PubMed ID: 18086808
[TBL] [Abstract][Full Text] [Related]
11. Differences in the carriage and the ability to utilize the serotype associated virulence plasmid in strains of Salmonella enterica serotype Typhimurium investigated by use of a self-transferable virulence plasmid, pOG669.
Olsen JE; Brown DJ; Thomsen LE; Platt DJ; Chadfield MS
Microb Pathog; 2004 Jun; 36(6):337-47. PubMed ID: 15120160
[TBL] [Abstract][Full Text] [Related]
12. Enterobacterial common antigen mutants of Salmonella enterica serovar Typhimurium establish a persistent infection and provide protection against subsequent lethal challenge.
Gilbreath JJ; Colvocoresses Dodds J; Rick PD; Soloski MJ; Merrell DS; Metcalf ES
Infect Immun; 2012 Jan; 80(1):441-50. PubMed ID: 22025511
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Salmonella enterica serovar Typhimurium and Choleraesuis slyA mutant strains for use in live attenuated oral vaccines.
Haneda T; Okada N; Kikuchi Y; Takagi M; Kurotaki T; Miki T; Arai S; Danbara H
Comp Immunol Microbiol Infect Dis; 2011 Sep; 34(5):399-409. PubMed ID: 21840053
[TBL] [Abstract][Full Text] [Related]
14. Mouse hepatitis virus strain UAB infection enhances resistance to Salmonella typhimurium in mice by inducing suppression of bacterial growth.
Fallon MT; Benjamin WH; Schoeb TR; Briles DE
Infect Immun; 1991 Mar; 59(3):852-6. PubMed ID: 1847697
[TBL] [Abstract][Full Text] [Related]
15. Dietary Bifidobacterium lactis (HN019) enhances resistance to oral Salmonella typhimurium infection in mice.
Shu Q; Lin H; Rutherfurd KJ; Fenwick SG; Prasad J; Gopal PK; Gill HS
Microbiol Immunol; 2000; 44(4):213-22. PubMed ID: 10832963
[TBL] [Abstract][Full Text] [Related]
16. Tackling the issue of environmental survival of live Salmonella Typhimurium vaccines: deletion of the lon gene.
Leyman B; Boyen F; Van Parys A; Verbrugghe E; Haesebrouck F; Pasmans F
Res Vet Sci; 2012 Dec; 93(3):1168-72. PubMed ID: 22683389
[TBL] [Abstract][Full Text] [Related]
17. Characterization and immunogenicity of Salmonella typhimurium SL1344 and UK-1 delta crp and delta cdt deletion mutants.
Zhang X; Kelly SM; Bollen WS; Curtiss R
Infect Immun; 1997 Dec; 65(12):5381-7. PubMed ID: 9393846
[TBL] [Abstract][Full Text] [Related]
18. Occurrence of secondary attenuating mutations in avirulent Salmonella typhimurium vaccine strains.
Lockman HA; Curtiss R
J Infect Dis; 1990 Dec; 162(6):1397-400. PubMed ID: 2230273
[TBL] [Abstract][Full Text] [Related]
19. Mice vaccinated with a non-virulent, aromatic-dependent mutant of Salmonella choleraesuis die from challenge with its virulent parent but survive challenge with Salmonella typhimurium.
Nnalue NA
J Med Microbiol; 1990 Apr; 31(4):225-33. PubMed ID: 2139129
[TBL] [Abstract][Full Text] [Related]
20. The type VI secretion system gene cluster of Salmonella typhimurium: required for full virulence in mice.
Liu J; Guo JT; Li YG; Johnston RN; Liu GR; Liu SL
J Basic Microbiol; 2013 Jul; 53(7):600-7. PubMed ID: 22961625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
